Key Evidence #1
reviewPublic scholarly dataCitation signal: 34
Ch chromium supplementation may improve OS parameters, however, due to high heterogeneity observed in the included studies, these findings should be interpreted with caution.
Tier-BPublic-ready6/12/2026
Chromium
Glucose and metabolic health markers is closer to a research marker, so it should be read separately from a directly felt benefit.
Representative tier calculated from paper evidence that passed the collection audit.
Papers analyzed
20
Caution signal
Low
Representative score
68.3
Glucose and metabolic health markersCholesterol and triglyceridesBlood pressure and vascular health markers
Main benefit evidence
The representative ingredient tier is calculated from these target-level evidence groups.
Glucose and metabolic health8 studiesTier-BGlucose and metabolic health markersFairly consistent positive signal in studiesResearch marker focusPatient-group studyThis card is closer to a measured biomarker or lab outcome than a directly felt user benefit.Closer to a research marker than a directly felt benefit.Open metrics>
Glucose and metabolic health
8 studiesTier-B
Glucose and metabolic health markers
Fairly consistent positive signal in studiesResearch marker focusPatient-group study
This card is closer to a measured biomarker or lab outcome than a directly felt user benefit.
Closer to a research marker than a directly felt benefit.
Open metrics
>Glucose and metabolic markers
No direct rate reported. Read direction and evidence strength together.
Evidence score
61.4
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Blood lipids2 studiesTier-CCholesterol and triglyceridesFairly consistent positive signal in studiesFelt benefit focusPatient-group studyPotential benefit studied in Blood lipids.Open metrics>
Blood lipids
2 studiesTier-C
Cholesterol and triglycerides
Fairly consistent positive signal in studiesFelt benefit focusPatient-group study
Potential benefit studied in Blood lipids.
Open metrics
>Cholesterol and triglycerides
No direct rate reported. Read direction and evidence strength together.
Evidence score
48.7
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Blood pressure and vascular health1 studiesTier-CBlood pressure and vascular health markersSome positive signal observedResearch marker focusPatient-group studyThis card is closer to a measured biomarker or lab outcome than a directly felt user benefit.Closer to a research marker than a directly felt benefit.Open metrics>
Blood pressure and vascular health
1 studiesTier-C
Blood pressure and vascular health markers
Some positive signal observedResearch marker focusPatient-group study
This card is closer to a measured biomarker or lab outcome than a directly felt user benefit.
Closer to a research marker than a directly felt benefit.
Open metrics
>Blood pressure and vascular markers
No direct rate reported. Read direction and evidence strength together.
Evidence score
44.0
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Women's health1 studiesTier-CMenstrual and women's healthSome positive signal observedFelt benefit focusPatient-group studyPotential benefit studied in Women's health.Open metrics>
Women's health
1 studiesTier-C
Menstrual and women's health
Some positive signal observedFelt benefit focusPatient-group study
Potential benefit studied in Women's health.
Open metrics
>Menstrual and women's health
No direct rate reported. Read direction and evidence strength together.
Evidence score
42.6
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Stress and mood1 studiesTier-CStress Response and Sleep ChangesSome positive signal observedFelt benefit focusSupplement contextThese findings come from stress response, cortisol, anxiety, or sleep outcomes. They may mix felt benefits with physiological markers.Open metrics>
Stress and mood
1 studiesTier-C
Stress Response and Sleep Changes
Some positive signal observedFelt benefit focusSupplement context
These findings come from stress response, cortisol, anxiety, or sleep outcomes. They may mix felt benefits with physiological markers.
Open metrics
>Stress and mood balance
No direct rate reported. Read direction and evidence strength together.
Evidence score
22.8
Score reflects signal strength. Tier also considers paper count, repetition, and study context.
Recent research
Updated This Month10 new papers
10 new papers were added in this period. No new risk signal was identified.
What's new
10 new papers were added.No new risk signal was identified.
Most notable recent finding
This is the most meaningful new study in the latest update.
Why it mattersIt ranked highest among the newly collected papers for this ingredient in the latest update.
View paperKey cautions to review
Standalone side-effect signals and combination cautions are listed separately.
Caution index
0.0
Caution band: Low
Caution signals
1
Side effects + combos + curated rules
Key precautions
No combination caution signal is clear enough to show right now. This does not guarantee safety.
Standalone side effects, combination cautions, and positive combos are separated below.
Standalone side effects
Genotoxicity (Comet assay: Tail length, Tail DNA, Olive Tail Moment)1 papers
Inorganic chromium chloride hexahydrate at 0.3 mg/kg induced dose- and form-related genetic damage in fish erythrocytes, with maximum comet parameters observed.animal · animal-studyEvidence summaries
Paper IDs and full lists are private. Only study types and summaries are shown.
Key Evidence #2
reviewPublic scholarly dataCitation signal: 144
A systematic review and meta‐analysis was conducted to assess the effects on metabolic profiles and safety of chromium supplementation in diabetes mellitus and the results were inconsistent.
Key Evidence #3
reviewPublic scholarly dataCitation signal: 86
Cr supplementation with brewer’s yeast may provide marginal benefits in lowering FPG in patients with T2DM compared to placebo however it did not have any effect on A1C.
3 more summariesLimited representative sample by study type.>
Public scholarly dataCitation signal: 69
observationalFour-month treatment with a dietary supplement containing cinnamon, chromium and carnosine decreased FPG and increased fat-free mass in overweight or obese pre-diabetic subjects, which might open up new avenues in the prevention of diabetes.
Public scholarly dataCitation signal: 61
reviewThe results of the current meta-analysis study might support the use of chromium supplementation for the improvement of glycemic control indices in T2DM patients.
Public scholarly dataCitation signal: 36
observationalThe initial findings support further larger trials to determine chromium’s efficacy in maintaining normal glucose regulation, reducing binge eating and related psychopathology, promoting modest weight loss, and reducing symptoms of depression in individuals wi
Chromium
arrow_backBack to listEvidence score: 68.3|Caution index: 0.0